Roel Klein J. K. Wolterink
AuthID: R-00F-B3N
1
TITLE: Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy Full Text
AUTHORS: Gong, Y; Wolterink, RGJK; Wang, JX; Bos, GMJ; Germeraad, WTV;
PUBLISHED: 2021, SOURCE: JOURNAL OF HEMATOLOGY & ONCOLOGY, VOLUME: 14, ISSUE: 1
AUTHORS: Gong, Y; Wolterink, RGJK; Wang, JX; Bos, GMJ; Germeraad, WTV;
PUBLISHED: 2021, SOURCE: JOURNAL OF HEMATOLOGY & ONCOLOGY, VOLUME: 14, ISSUE: 1
INDEXED IN:
Scopus
WOS


2
TITLE: Defucosylation of Tumor-Specific Humanized Anti-MUC1 Monoclonal Antibody Enhances NK Cell-Mediated Anti-Tumor Cell Cytotoxicity Full Text
AUTHORS: Gong, Y; Wolterink, RGJK; Gulaia, V; Cloosen, S; Ehlers, FAI; Wieten, L; Graus, YF; Bos, GMJ; Germeraad, WTV;
PUBLISHED: 2021, SOURCE: CANCERS, VOLUME: 13, ISSUE: 11
AUTHORS: Gong, Y; Wolterink, RGJK; Gulaia, V; Cloosen, S; Ehlers, FAI; Wieten, L; Graus, YF; Bos, GMJ; Germeraad, WTV;
PUBLISHED: 2021, SOURCE: CANCERS, VOLUME: 13, ISSUE: 11
INDEXED IN:
Scopus
WOS


3
TITLE: Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5(+) and IL-13(+) type 2 innate lymphoid cells
AUTHORS: Roel Klein J K Wolterink; Nicolas Serafini; Menno van Nimwegen; Christian A J Vosshenrich; Marjolein J W de Bruijn; Diogo Fonseca Pereira ; Henrique Veiga Fernandes; Rudi W Hendriks; James P Di Santo;
PUBLISHED: 2013, SOURCE: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, VOLUME: 110, ISSUE: 25
AUTHORS: Roel Klein J K Wolterink; Nicolas Serafini; Menno van Nimwegen; Christian A J Vosshenrich; Marjolein J W de Bruijn; Diogo Fonseca Pereira ; Henrique Veiga Fernandes; Rudi W Hendriks; James P Di Santo;
PUBLISHED: 2013, SOURCE: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, VOLUME: 110, ISSUE: 25